Currently viewing the tag: "Dendreon"
Dandrit is given a chance to measure up the competition at the Cancer Vaccine Conference in Boston late june…
Speakers are amongst others: dendreon, Bristol-Myers Squibb, Immunovaccine, Novartis, AstraZeneca, all among the top tier cancer vaccine companies of the world
the whole program is available here:
http://medicoinvestor.com/wp-content/uploads/2012/06/agenda.pdf
DanDrit will be represented by Dr. Eric Leire, […]
Dandrit ‘s technique is based on Dendritic Cells, garland science made this easy-to-understand youtube video on the development of Dendritic Cells
http://www.youtube.com/watch?v=ZuccruG_79M
this stops at where the T-cells enters :)…
but don’t despair I’ve found another from KhanAcademy.org on the cytotoxic T-cells http://www.youtube.com/watch?v=xaz5ftvZCyI&feature=related (these are the cells that attack cancer-cells)
So far the only FDA approved […]
As some of you know, Dandrit is planning a merger with DKTI A/S a company listed on the danish stock exchange.
DKTI is cash rich but with no real purpose, quite the oppsite to Dandrit – who is a company with a message – but precious little cash. So it looks like a match made […]
Dandrit strengthens its European Patent base. This company has potential of surpassing rival Dendreon in the field of Cancer Vaccine Astonishing – but true….
Dandrit A/s is through merger of cash-rich DKTI A/S securing a financial platform for expansion and a platform on the Copenhagen Stock Exchange. Ongoing talks – that were first publicized late […]
Ongoing debate
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Thomas Goldberg on Good Discussion on Bronte Capital’s long thesis on Herbalife
- Spekulant.dk on dashboard
- Muldyr on dashboard
- kasperlindvig on dashboard
